From correlation to causality: Microarrays, cancer, and cancer treatment

BioTechniques

Volumn 34, Issue 3 SUPPL., 2003, Pages

  O'Neill, Geraldine M ^a   Catchpoole, Daniel R ^a   Golemis, Erica A ^b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ANTINEOPLASTIC AGENT; DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; B CELL LYMPHOMA; BREAST TUMOR; CANCER THERAPY; CARCINOGENESIS; DNA MICROARRAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; SMALL CELL SARCOMA; TUMOR CLASSIFICATION; ANIMAL; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METHODOLOGY; NEOPLASM; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA, NEOPLASM; DRUG EVALUATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME;

EID: 0037337887     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/mar03oneil     Document Type: Review

References (60)

1. Khan, J., R. Simon, M. Bittner, Y. Chen, S.B. Leighton, T. Pohida, P.D. Smith, Y. Jiang, et al. 1998. Gene expression profiling of alveolar rhab-domyosarcoma with cDNA microarrays. Cancer Res. 58:5009-5013.
2. Golub, T.R., A. Goga, G.F. Barker, D.E.H. Afar, J. McLaughlin, S.K. Bohlander, J.D. Rowley, O.N. Witte, and D.G. Gilliland. 1996. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol. 16:4107-4116.
3. Alizadeh, A.A., M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
4. Perou, C.M., T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, et al. 2000. Molecular portraits of human breast tumours. Nature 406:747-752.
5. Khan, J., J.S. Wei, M. Ringner, L.H. Saal, M. Ladanyi, F. Westermann, F. Berthold, M. Schwab, et al. 2001. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med. 7:673-679.
6. Yeoh, E.J., M.E. Ross, S.A. Shurtleff, W.K. Williams, D. Patel, R. Mahfouz, F.G. Behm, S.C. Raimondi, et al. 2002. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1:133-143.
7. Rosenwald, A., G. Wright, W.C. Chan, J.M. Connors, E. Campo, R.I. Fisher, R.D. Gascoyne, H.K. Muller-Hermelink, et al. 2002. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346:1937-1947.
8. van't Veer, L.J., H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536.
9. Birrell, G.W., J.A. Brown, H.I. Wu, G. Giaever, A.M. Chu, R.W. Davis, and J.M. Brown. 2002. Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents. Proc. Natl. Acad. Sci. USA 99:18778-8783.
10. Fleming, J.A., E.S. Lightcap, S. Sadis, V. Thoroddsen, C.E. Bulawa, and R.K. Blackman. 2002. Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341. Proc. Natl. Acad. Sci. USA 99:1461-1466.
11. Dan, S., T. Tsunoda, O. Kitahara, R. Yanagawa, H. Zembutsu, T. Katagiri, K. Yamazaki, Y. Nakamura, and T. Yamori. 2002. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res. 62:1139-1147.
12. Mitsiades, N., C.S. Mitsiades, V. Poulaki, D. Chauhan, G. Fanourakis, X. Gu, C. Bailey, M. Joseph, et al. 2002. Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc. Natl. Acad. Sci. USA 99:14374-14379.
13. Scherf, U., D.T. Ross, M. Waltham, L.H. Smith, J.K. Lee, L. Tanabe, K.W. Kohn, W.C. Reinhold, et al. 2000. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24:236-244.
14. Zembutsu, H., Y. Ohnishi, T. Tsunoda, Y. Furukawa, T. Katagiri, Y. Ueyama, N. Tamaoki, T. Nomura, et al. 2002. Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res. 62:518-527.
15. Kuruvilla, F.G., A.F. Shamji, S.M. Sternson, P.J. Hergenrother, and S.L. Schreiber. 2002. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature 416:653-657.
16. Marton, M.J., J.L. DeRisi, H.A. Bennett, V.R. Iyer, M.R. Meyer, C.J. Roberts, R. Stoughton, J. Burchard, et al. 1998. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med. 4:1293-1301.
17. Qian, Z., A.A. Fernald, L.A. Godley, R.A. Larson, and M.M. Le Beau. 2002. Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 99:14925-14930.
18. Calvo, A., N. Xiao, J. Kang, C.J. Best, I. Leiva, M.R. Emmert-Buck, C. Jorcyk, and J.E. Green. 2002. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res. 62:5325-5335.
19. Ono, K., T. Tanaka, T. Tsunoda, O. Kitahara, C. Kihara, A. Okamoto, K. Ochiai, T. Takagi, and Y. Nakamura. 2000. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res. 60:5007-5011.
20. Ross, D.T., U. Scherf, M.B. Eisen, C.M. Perou, C. Rees, P. Spellman, V. Iyer, S.S. Jeffrey, et al. 2000. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24:227-235.
21. Yoon, H., S. Liyanarachchi, F.A. Wright, R. Davuluri, J.C. Lockman, A. De La Chapelle, and N.S. Pellegata. 2002. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53. Proc. Natl. Acad. Sci. USA 99:15632-15637.
22. Hanahan, D. and R.A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
23. Gygi, S.P., Y. Rochon, B.R. Franza, and R. Aebersold. 1999. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19:1720-1730.
24. Holland, M.J. 2002. Transcript abundance in yeast varies over six orders of magnitude. J. Biol. Chem. 277:14363-14366.
25. Dudley, A.M., J. Aach, M.A. Steffen, and G.M. Church. 2002. Measuring absolute expression with microarrays with a calibrated reference sample and an extended signal intensity range. Proc. Natl. Acad. Sci. USA 99:7554-7559.
26. Gunning, P. Protein Isoforms and Isozymes. In D.N. Cooper (Ed.), Encyclopedia of the Human Genome. Macmillan Reference Ltd., Nature Publishing Group, London. (In press.)
27. Vogelstein, B. and K.W. Kinzler. 1993. The multistep nature of cancer. Trends Genet. 9:138-141.
28. Cho, R.J., M. Huang, M.J. Campbell, H. Dong, L. Steinmetz, L. Sapinoso, G. Hampton, S.J. Elledge, et al. 2001. Transcriptional regulation and function during the human cell cycle. Nat. Genet. 27:48-54.
29. Whitfield, M.L., G. Sherlock, A.J. Saldanha, J.I. Murray, C.A. Ball, K.E. Alexander, J.C. Matese, C.M. Perou, et al. 2002. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13:1977-2000.
30. Iscove, N.N., M. Barbara, M. Gu, M. Gibson, C. Modi, and N. Winegarden. 2002. Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. Nat. Biotechnol. 20:940-943.
31. Levsky, J.M., S.M. Shenoy, R.C. Pezo, and R.H. Singer. 2002. Single-cell gene expression profiling. Science 297:836-840.
32. Wang, W., J.B. Wyckoff, V.C. Frohlich, Y. Oleynikov, S. Huttelmaier, J. Zavadil, L. Cermak, E.P. Bottinger, et al. 2002. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res. 62:6278-6288.
33. Griffin, T.J., S.P. Gygi, T. Ideker, B. Rist, J. Eng, L. Hood, and R. Aebersold. 2002. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell Proteomics 1:323-333.
34. Ideker, T., V. Thorsson, J.A. Ranish, R. Christmas, J. Buhler, J.K. Eng, R. Bumgarner, D.R. Goodlett, et al. 2001. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292:929-934.
35. Kolch, W. 2000. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351:289-305.
36. Clark, E.A., T.R. Golub, E.S. Lander, and R.O. Hynes. 2000. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532-535.
37. Saha, S., A. Bardelli, P. Buckhaults, V.E. Velculescu, C. Rago, B. St Croix, K.E. Romans, M.A. Choti, et al. 2001. A phosphatase associated with metastasis of colorectal cancer. Science 294:1343-1346.
38. Schulze, A., K. Lehmann, H.B. Jefferies, M. McMahon, and J. Downward. 2001. Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev. 15:981-994.
39. Roberts, C.J., B. Nelson, M.J. Marton, R. Stoughton, M.R. Meyer, H.A. Bennett, Y.D. He, H. Dai, et al. 2000. Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. Science 287:873-880.
40. Giaever, G., A.M. Chu, L. Ni, C. Connelly, L. Riles, S. Veronneau, S. Dow, A. Lucau-Danila, et al. 2002. Functional profiling of the Saccharomyces cerevisiae genome. Nature 418:387-391.
41. Winzeler, E.A., D.D. Shoemaker, A. Astromoff, H. Liang, K. Anderson, B. Andre, R. Bangham, R. Benito, et al. 1999. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285:901-906.
42. Johnstone, R.W., A.A. Ruefli, and S.W. Lowe. 2002. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108:153-164.
43. Lam, L.T., O.K. Pickeral, A.C. Peng, A. Rosenwald, E.M. Hurt, J.M. Giltnane, L.M. Averett, H. Zhao, et al. 2001. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol. 2:RESEARCH0041.
44. Gasch, A.P., P.T. Spellman, C.M. Kao, O, Carmel-Harel, M.B. Eisen, G. Storz, D. Botstein, and P.O. Brown. 2000. Genomic expression programs in the response of yeast cells to environmental changes. Mol. Biol. Cell 11:4241-4257.
45. Hughes, T.R., M.J. Marton, A.R. Jones, C.J. Roberts, R. Stoughton, C.D. Armour, H.A. Bennett, E. Coffey, et al. 2000. Functional discovery via a compendium of expression profiles. Cell 102:109-126.
46. Jelinsky, S.A., P. Estep, G.M. Church, and L.D. Samson. 2000. Regulatory networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae cells: Rpn4 links base excision repair with proteasomes. Mol. Cell. Biol. 261:8157-8167.
47. Cohen, B.A., R.D. Mitra, J.D. Hughes, and G.M. Church. 2000. A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression. Nat. Genet. 26:183-186.
48. Oleksiak, M.F., G.A. Churchill, and D.L. Crawford. 2002. Variation in gene expression within and among natural populations. Nat. Genet. 32:261-266.
49. Pritchard, C.C., L. Hsu, J. Delrow, and P.S. Nelson. 2001. Project normal: defining normal variance in mouse gene expression. Proc. Natl. Acad. Sci. USA 98:13266-13271.
50. Turton, N.J., D.J. Judah, J. Riley, R. Davies, D. Lipson, J.A. Styles, A.G. Smith, and T.W. Gant. 2001. Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance. Oncogene 20:1300-1306.
51. Tuschl, T., P.D. Zamore, R. Lehmann, D.P. Bartel, and P.A. Sharp. 1999. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13:3191-3197.
52. Steinmetz, L.M., C. Scharfe, A.M. Deutschbauer, D. Mokranjac, Z.S. Herman, T. Jones, A.M. Chu, G. Giaever, et al. 2002. Systematic screen for human disease genes in yeast. Nat. Genet. 31:400-404.
53. Boutros, M., H. Agaisse, and N. Perrimon. 2002. Sequential activation of signaling pathways during innate immune responses in Drosophila. Dev. Cell 3:711-722.
54. Shaffer, A.L., A. Rosenwald, E.M. Hurt, J.M. Giltnane, L.T. Lam, O.K. Pickeral, and L.M. Staudt. 2001. Signatures of the immune response. Immunity 15:375-385.
55. Vaudry, D., P.J. Stork, P. Lazarovici, and L.E. Eiden. 2002. Signaling pathways for PC12 cell differentiation: making the right connections. Science 296:1648-1649.
56. Fambrough, D., K. McClure, A. Kazlauskas, and E.S. Lander. 1999. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell 97:727-741.
57. Sweeney, C., D. Fambrough, C. Huard, A.J. Diamonti, E.S. Lander, L.C. Cantley, and K.L. Carraway, III. 2001. Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors. J. Biol. Chem. 276:22685-22698.
58. Steffen, M.A., A.A. Petti, J. Aach, P. D'Haeseleer, and G.M. Church. 2002. Automated modelling of signal transduction networks. BMC Bioinformatics 3:34-45.
59. Harris, K., R.E. Lamson, B. Nelson, T.R. Hughes, M.J. Marton, C.J. Roberts, C. Boone, and P.M. Pryciak. 2001. Role of scaffolds in MAP kinase pathway specificity revealed by custom design of pathway-dedicated signaling proteins. Curr. Biol. 11:1815-1824.
60. Serebriiskii, I.G., O. Mitina, E. Pugacheva, E. Benevolenskaya, E. Kotova, G.G. Toby, V. Khazak, W.G. Kaelin, et al. 2002. Detection of peptides, proteins, and drugs that selectively interact with protein targets. Genome Res. 12:1785-1791.